The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST)
.If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Multiparameter flow cytometric analysis of CD123 (IL-3 Receptor α) expression on Human peripheral blood leukocyte populations. Human whole blood was stained with either BD Horizon™ RB705 Mouse IgG2a, κ Isotype Control (Cat. No. 570254; Left Plot) or BD Horizon™ RB705 Mouse Anti-Human CD123 (IL-3 Receptor α) antibody (Cat. No. 570251/570252; Right Plot). The erythrocytes were lysed with BD Pharm Lyse™ (Cat. No. 555899). The bivariate pseudocolor density plot showing the correlated expression of CD123 (IL-3 Receptor α) [or Ig Isotype control staining] versus side light-scatter (SSC-A) signals was derived from gated events with the forward and side light-scatter characteristics of viable leukocytes. Flow cytometry and data analysis were performed using a BD FACSymphony™ A5 Cell Analyzer System and FlowJo™ software.
Multiparameter flow cytometric analysis of CD123 (IL-3 Receptor α) expression on Human peripheral blood leukocyte populations. Human whole blood was stained with either BD Horizon™ RB705 Mouse IgG2a, κ Isotype Control (Cat. No. 570254; Left Plot) or BD Horizon™ RB705 Mouse Anti-Human CD123 (IL-3 Receptor α) antibody (Cat. No. 570251/570252; Right Plot). The erythrocytes were lysed with BD Pharm Lyse™ (Cat. No. 555899). The bivariate pseudocolor density plot showing the correlated expression of CD123 (IL-3 Receptor α) [or Ig Isotype control staining] versus side light-scatter (SSC-A) signals was derived from gated events with the forward and side light-scatter characteristics of viable leukocytes. Flow cytometry and data analysis were performed using a BD FACSymphony™ A5 Cell Analyzer System and FlowJo™ software.
Multiparameter flow cytometric analysis of CD123 (IL-3 Receptor α) expression on Human peripheral blood leukocyte populations. Human whole blood was stained with either BD Horizon™ RB705 Mouse IgG2a, κ Isotype Control (Cat. No. 570254; Left Plot) or BD Horizon™ RB705 Mouse Anti-Human CD123 (IL-3 Receptor α) antibody (Cat. No. 570251/570252; Right Plot). The erythrocytes were lysed with BD Pharm Lyse™ (Cat. No. 555899). The bivariate pseudocolor density plot showing the correlated expression of CD123 (IL-3 Receptor α) [or Ig Isotype control staining] versus side light-scatter (SSC-A) signals was derived from gated events with the forward and side light-scatter characteristics of viable leukocytes. Flow cytometry and data analysis were performed using a BD FACSymphony™ A5 Cell Analyzer System and FlowJo™ software.
Multiparameter flow cytometric analysis of CD123 (IL-3 Receptor α) expression on Human peripheral blood leukocyte populations. Human whole blood was stained with either BD Horizon™ RB705 Mouse IgG2a, κ Isotype Control (Cat. No. 570254; Left Plot) or BD Horizon™ RB705 Mouse Anti-Human CD123 (IL-3 Receptor α) antibody (Cat. No. 570251/570252; Right Plot). The erythrocytes were lysed with BD Pharm Lyse™ (Cat. No. 555899). The bivariate pseudocolor density plot showing the correlated expression of CD123 (IL-3 Receptor α) [or Ig Isotype control staining] versus side light-scatter (SSC-A) signals was derived from gated events with the forward and side light-scatter characteristics of viable leukocytes. Flow cytometry and data analysis were performed using a BD FACSymphony™ A5 Cell Analyzer System and FlowJo™ software.
Multiparameter flow cytometric analysis of CD123 (IL-3 Receptor α) expression on Human peripheral blood leukocyte populations. Human whole blood was stained with either BD Horizon™ RB705 Mouse IgG2a, κ Isotype Control (Cat. No. 570254; Left Plot) or BD Horizon™ RB705 Mouse Anti-Human CD123 (IL-3 Receptor α) antibody (Cat. No. 570251/570252; Right Plot). The erythrocytes were lysed with BD Pharm Lyse™ (Cat. No. 555899). The bivariate pseudocolor density plot showing the correlated expression of CD123 (IL-3 Receptor α) [or Ig Isotype control staining] versus side light-scatter (SSC-A) signals was derived from gated events with the forward and side light-scatter characteristics of viable leukocytes. Flow cytometry and data analysis were performed using a BD FACSymphony™ A5 Cell Analyzer System and FlowJo™ software.
Multiparameter flow cytometric analysis of CD123 (IL-3 Receptor α) expression on Human peripheral blood leukocyte populations. Human whole blood was stained with either BD Horizon™ RB705 Mouse IgG2a, κ Isotype Control (Cat. No. 570254; Left Plot) or BD Horizon™ RB705 Mouse Anti-Human CD123 (IL-3 Receptor α) antibody (Cat. No. 570251/570252; Right Plot). The erythrocytes were lysed with BD Pharm Lyse™ (Cat. No. 555899). The bivariate pseudocolor density plot showing the correlated expression of CD123 (IL-3 Receptor α) [or Ig Isotype control staining] versus side light-scatter (SSC-A) signals was derived from gated events with the forward and side light-scatter characteristics of viable leukocytes. Flow cytometry and data analysis were performed using a BD FACSymphony™ A5 Cell Analyzer System and FlowJo™ software.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
BD® CompBeads can be used as surrogates to assess fluorescence spillover (compensation). When fluorochrome conjugated antibodies are bound to BD® CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and BD® CompBeads to ensure that BD® CompBeads are appropriate for your specific cellular application.
The 7G3 monoclonal antibody specifically recognizes human CD123, the 70 kDa IL-3 Receptor α (IL-3Rα) chain. CD123 associates with CD131, the 120-140 kDa Common β chain to form the IL-3 Receptor Complex. CD131 is shared with the receptors for interleukins IL-5 and GM-CSF. IL-3Rα is expressed on hematopoietic progenitors and plays an important role in hematopoietic progenitor cell growth and differentiation. It is also expressed by mast cells, macrophages and a CD5+ B cell subset. This antibody has been reported to block the binding of 125I-IL-3 to high and low affinity IL-3 receptors. In functional experiments, this antibody was found to inhibit acute myeloid leukemia cell proliferation, basophil histamine release, endothelial cell-mediated IL-8 secretion, and neutrophil transmigration. This antibody has been reported to be useful for immunoprecipitation, Western blot and immunofluorescent staining for flow cytometry. At the Fifth HLDA Workshop, the human IL-3 receptor was designated CD123.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.